Full Product Details
Author: Joao L. de Quevedo, MD, PhD (Professor of Psychiatry at the McGovern Medical School, The University of Texas Health Science Center at Houston, TX, USA) ,
Patricio Riva-Posse (Emory University, Atlanta, GA, USA) ,
William V. Bobo (Mayo Clinic, Jacksonville, FL, USA)
Publisher: Elsevier Science Publishing Co Inc
Imprint: Academic Press Inc
Weight: 1.650kg
ISBN: 9780128240670
ISBN 10: 0128240679
Pages: 612
Publication Date: 04 April 2022
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: Manufactured on demand
We will order this item for you from a manufactured on demand supplier.
Reviews
*4 stars* ""...presents a comprehensive, extensive review of the current understanding of depression, its epidemiology, presentation, predictors, socioeconomic burden, neurobiology, and effectiveness of pharmacotherapy and nonpharmacological and psychotherapeutic interventions. This book extensively reviews the current understanding of treatment-resistant depression (TRD), covering a wide variety of topics including disease burden, presentation, and course…. [A]ppropriate for a broad audience,… covers a broad range of topics across 500-plus pages and 40 chapters,… a resource that should be on the shelves of those managing this complicated and challenging population.” --©Doody’s Review Service, 2023, Michael Easton, MD (Rush University Medical Center)
Author Information
Dr. João Luciano de Quevedo, MD, PhD, is a Professor of Psychiatry at the McGovern Medical School, the University of Texas Health Science Center at Houston, where he is the Vice-Chair for Faculty Development and Outreach, Director of the Translational Psychiatry Program, and Director of the Treatment-Resistant Depression Clinic. Before moving to Houston, he was a Dean at the University of Southern Santa Catarina Medical School, Criciúma, SC, Brazil, where he is still an Adjunct Professor of Psychiatry. He is also Editor-in-Chief of the Brazilian Journal of Psychiatry and Director of the Continuous Medical Education Program in Psychiatry (PROPSIQ) of the Brazilian Psychiatric Association. Dr. Quevedo’s research interest is neurobiology of psychiatric disorders, particularly mood disorders, and he is a specialist in both unipolar and bipolar treatment–resistant depression. He is author of nearly 600 publications and 10 scientific books. Dr. Patricio Riva-Posse, MD is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine. After completing his training in Neurology and in Psychiatry, he has focused his clinical and research work in the field of treatment resistant mood disorders. He is the Director of the Treatment Resistant Depression Clinic, and Director of Neuromodulation Services. He conducts research in invasive and non-invasive neuromodulation as well as novel pharmacological approaches. He is an investigator in NIH-funded project studying subcallosal cingulate deep brain stimulation. Born in Argentina, he earned his Medical Doctor degree from the Universidad de Buenos Aires. Dr. William V. Bobo, M.D., M.P.H., is Professor of Psychiatry at the Mayo Clinic Alix School of Medicine and Chair, Department of Psychiatry & Psychology at Mayo Florida, where he also serves as the Medical Director for Leadership Development. His clinical and research interests are focused on the treatment of patients with refractory mood disorders and on examining and predicting the clinical effects — both beneficial and harmful--of medications used to treat people with severe mood disorders. He lives with his wife in Jacksonville, Florida.
